Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What is the SEC filing out this evening all about with REN? The company filed to Register an aditional 1,620,000 shares of common stock at $6.45.
Is the company raising $10,000,000 for what?
By FAR The biggest thing increasing is the amount of shares that continue to be dumped and the biggest thing decreasing month after month for YEARS is shareholder value.
Spot on. Average US Car Wash business does more in annual revenue than DBMM. Something to ponder.
your statement about making light of the continuous dilution was what I wanted to address. This company has been talking "opportunity after opporunity" after forward looking statement after forward looking statement for YEARS. More US Car Wash business's have better revenue than DBMM. I did rethink my strategy years ago and got out. Unfortunately it was much too late but I learned a great lesson that is still serving me VERY well.
"i love when people cry huge dilution lol" How else do you explain a 3 year chart where the price has gone from $30ish to less than a penny? YUUUUUGE MASSIVE Dilution with a website business doing less revenue than most US Car Wash businesses. Nothing funny about it. Sad part is that people keep drinking the koolaide forward looking statements and throwing away their hard earn money.
Posted article yesterday from Seeking Alpha. Author seems to know his stuff. Stock took a good tumble today. Very volatile stock so could be back up tomorrow if the broader market is up. I do think the fundamentals are not good with the company apparently short on cash. Between a rock and a hard place and I think the share price will reflect that in coming months.
Imminent Dilution is the only way out... well researched article from Seeking Alpha
http://seekingalpha.com/article/3913886-timkensteel-imminent-dilution-way?ifp=0
Congrats Beer!
Thanks, I think so. Chart looks good and volume strong. Little risk IMO.
Thanks Marilynt. Just bought looking at the chart and seeing the volume.
Grabbed 3,000 shares today. Avg $1.70ish. GLTA.
Hello Stocktrademan. You looking to buy or sell short?
take it from someone who knows, you'll regret pumping this company. Or as some would call it, doing the devils work.
Are they smart? Sure, they know exactly what they're doing.
Does Reggie James have credibility? Yes he does.
Does the company exploit that to sell millions upon millions of shares? I think the answer is pretty obvious.
So, if you can't get enough of press releases with crafty forward looking statements that create false expectations designed to coax investors into buying shares while the company is diluting shares like a whore on crack cocaine, (see 1 or 5 or 10 year chart) stealing all your hard earned money, you are going to LOVE LOVE LOVE this company.
So glad I moved on years ago. I lost a great deal of money. I was such a fool. Don't be foolish me.
I think both statements are true. Here's a difficulty I think many Investor's are having with today's language on the FDA's position on CVOT:
$ESPR's previous PR and this one, unfortunately. Which is:
"…will not require (CVOT)"
vs
"…(CVOT) could be required."
That's a pretty big discrepancy from what they originally communicated to investors versus what they said today with HUGE a implication.
Management screwed up.
Company hasn't been communicating to investors which doesn't help.
I know the company can't say much but how about "we remain as enthusiastic as ever and look forward to updating shareholders..."
Short interest report just out: 4,110,783 shares short
http://www.nasdaq.com/symbol/espr/short-interest
Could get real interesting depending on what's cooking / partnership? buyout? and the FDA minutes due out any day before the end of the month.
Solid couple of days... the next few days should be interesting.
Between now and the end of the month
espr $ESPR short interest report out: 4.280,900 shares short http://www.nasdaq.com/symbol/espr/short-interest
just waiting on the FDA meeting minutes...
Thanks for posting, very helpful GDL.
Grabbed some shares today. Details of FDA meeting minutes out soon....
Short Interest report our tomorrow....
sitting bid for some Sept4 $110 Aapl lotto calls
Very nice
Good thoughts
Great post Roy. Thank you
How did ESPR trade the last time Needham upgraded to Strong Buy?
Stock jumped over 10% on fairly heavy volume. Pretty certain there is a big short in this after the company put our VERY Positive Press a few days ago.... "Clear Path to Approval" Should see some solid short covering today with shorts well over 10% of 22.5Mil OS.
Last time Needham upgraded to Strong Buy went from 61.67 to 69.96
2015/08/10 61.67 69.96 59.70 68.29 2,265,003 68.29
Needham upgrades ESPR to Strong buy. Remember how the stock did after the last time Needham upgraded? Me thinks it's a good day to own shares of ESPR.
http://www.marketbeat.com/stocks/NASDAQ/ESPR/?RegistrationCode=SocialMedia-StockTwits
ESPR on a Rampage today! That was fun. Still holding a couple hundred shares. BOOM in AH!!!!! WOW!!! Well my Calls are sure looking nice for tomorrow
ETC-1002 will be the only one in pill form. That along I think is pretty huge. I'm not an expert on this stock by any means. Just going with a good gut feeling on a strong management team with a record of strong success with huge upside potential.
I thought they said they would publish something in mid September
nicely done
Monster day yesterday. Beautiful confirmation continuation candle of the Friday's green candle. Onward & Upward. Will be interesting to see the short interest report that comes out after 4 today. Looks to have been a lot of covering yesterday and expect more today IMO.
Needham & Company upgraded Esperion Therapeutics (NASDAQ: ESPR) from Buy to Strong Buy with a price target of $130.00.
Analyst Chan Messer commented, "ESPR shares have recently pulled back over regulatory concerns. Some investors feel that an evolution of thinking at the FDA about cholesterol lowering could result in a higher bar for approval and/or a more restrictive label for ETC-1002. We disagree and are more confident than ever that FDA will agree to a development plan targeting a broad based label for LDL reduction. Specifically, we believe the plan will not require a completed cardiovascular outcomes trial (CVOT) as a prerequisite for any patient population. We upgrade ESPR shares to Strong Buy and would use the pullback as a buying opportunity."
http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Upgrades+Esperion+Therapeutics+%28ESPR%29+to+Strong+Buy%3B+Shares+Will+Rebound/10796334.html
Really good post I found about the so called "concerns" from 1 analyst:
Its amazing how much damage an analyst can do by suggesting a drug might have efficacy or safety problems. Statins & PSK9's have shown to cause a number of adverse effects.
1. - I knew the analyst was a joke when he failed to mention 1 of 4 adverse effects in the latest study was from a guy hitting himself in the head with a knife.
2. In the latest downgrade he compares TAK-475 to ETC-1002. That's a stupid comparison since ETC-1002 works upstream to statins & TAK-475 works downstream to statins & they both act on different targets. In addition what does it matter if ETC-1002 was less effective in combination with high dose statins? ETC-1002 is aimed at the stain intolerant population. TAK-475's development was stopped after Phase II due to elevated liver enzymes & nothing in ETC-1002's phase II studies indicate a similar problem. Less
Investor Conference Call tomorrow at 4:30. Stock is sitting at it's 50 week Moving Average and selling looks to have subsided. Higher high and lower low so far for the day. Shorts are covering and stock looks poised to go higher IMHO.
Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers, today announced it will host a conference call and webcast to provide program updates and financial results for the second quarter 2015. The conference call and webcast will take place on Thursday, August 6, 2015 at 4:30 p.m. Eastern Time.
The call can be accessed by dialing (877) 831-3840 (domestic) or (253) 237-1184 (international) five minutes prior to the start of the call and providing access code 80104515. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the Esperion website at www.esperion.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for two weeks.
Paul, I'm inclined to agree but I'm no Nastradamus when it comes to predicting the market. I just try to trade off support and resistance. Have a feeling the market will make us wait toward the end of the day. Greece, China, whatever... start in a hole probably and work our way up. Always interesting on option expiry day.
Anyway I enjoy all the different perspectives on the board.
Unbelieveable. Glad I sold some when I did...
Filled Sell 100 ESPR Limit 97.2064 -- -- 11:28:27 07/24/15
Grabbed some options at EOD
Filled Buy to Open 5 ESPR Aug 21 2015 75.0 Call Limit 7.33 -- -- 15:41:51 07/24/15
DTC has a restriction on this stock so most brokers including Ameritrade won't allow trading. Not that I would be interesting in buying.
So if you like a lotto, you'd be better off trading options of Apple or SPY IMO.
Options up 100% and my shares up over 8% today. Sold half my options and a few shares. Gap up tomorrow?
What goes along nicely with a great chart set up? How about a fabulous filing and press release: (up 3+% Pre-market)
Esperion Therapeutics Announces Removal Of 240 Mg Partial Clinical Hold For Etc-1002
http://www.conferencecalltranscripts.org/8/summary2/?id=1827976
ESPR up 2.4% today with a nice chart set up.